In addition, the frequency of IDH mutation strongly correlates with the tumor type, i.e., IDH mutations exist at a much higher frequency in lower grade gliomas than glioblastomas; therefore, there is a need to remove tumor type as a confounding factor in IDH mutation status. The gene discussed is IDH1; the disease is glioblastoma.